Status:
UNKNOWN
The Prevelance Rate of Human Cytomegalovirus (HCMV), Epstein-Barr Virus (EBV) and Human Herpes Virus (HHV-6) in a Saliva of the Patient With Periodantitis
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Cytomegalovirus
Epstein-Barr Virus Infections
Eligibility:
All Genders
18-80 years
Brief Summary
The purpose of this study is to study the prevalence of EBV, HCMV, HHV-6 in saliva and on the toothbrush patient with periodontitis.
Detailed Description
Human cytomegalovirus (HCMV), Epstein-Barr virus (EBV) Human Herpes virus6 (HHV-6)
Eligibility Criteria
Inclusion
- Patient with peridontitis
Exclusion
- Previous periodontal treatment in last 3 month
- Toothbrushing disability
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01248598
Start Date
October 1 2010
Last Update
November 25 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Periodontology, School of Graduate Dentistry Rambam Health care campus
Haifa, Israel